CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) has been ranked number one of 68 named EHR vendors in a Black Book Research user satisfaction survey globally. The report surveyed 4,056 current EHR ...
It has been about a month since the last earnings report for AllScripts Healthcare (MDRX). Shares have lost about 7% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
In its third-quarter 2022 earnings report posted Nov. 3, revenues for Veradigm, Allscripts’ life sciences and payer business, were $145 million compared with $137 million in the previous third quarter ...
Allscripts has agreed to pay $145 million to resolve potential civil and criminal liability in connection to a Department of Justice investigation into the business practices of Practice Fusion, a ...
CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for community hospitals according to new survey results from Black Book ...
EHR vendor Allscripts reported a loss of $182.2 million in 2019, a plummeting bottom line compared to 2018's $407.8 million profit. The loss came despite slight topline growth. The Chicago-based ...
The life sciences leg of the Veradigm data analytics business is gaining traction as the industry shifts to real-world evidence as a fundamental pillar of drug discovery, Allscripts executives said.
Allscripts said clients using its Professional EHR experienced unscheduled downtime Dec. 17, but that the issue has since been resolved, a company spokesperson told Becker's Hospital Review Dec. 19.
CHICAGO--(BUSINESS WIRE)-- Allscripts (NASDAQ:MDRX) announced today the execution of a definitive agreement to sell its CarePort Health (“CarePort”) business to WellSky Corp., a global health and ...
Allscripts is seeing strong growth in its life sciences data business as the market heats up among large health IT vendors. That business, along with the steady return of patient volumes among its ...
Allscripts has agreed to sell its CarePort Health business to WellSky, which is backed by TPG Capital and Leonard Green & Partners. The price of the sale is $1.35 billion. William Blair and J.P.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results